Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial

Paz-Ares, L (author)

Tan, EH (author)

O'Byrne, K (author)

show more...

Zhang, L (author)

Hirsh, V (author)

Boyer, M (author)

Yang, JCH (author)

Mok, T (author)

Lee, KH (author)

Lu, S (author)

Shi, Y (author)

Lee, DH (author)

Laskin, J (author)

Kim, DW (author)

Laurie, SA (author)

Kolbeck, K (author)

Karolinska Institutet

Fan, J (author)

Dodd, N (author)

Marten, A (author)

Park, K (author)

show less...

 (creator_code:org_t)

Elsevier BV, 2017

2017

English.

In: Annals of oncology : official journal of the European Society for Medical Oncology. - : Elsevier BV. - 1569-8041. ; 28:2, s. 270-277

Related links:

https://doi.org/10.1...

show more...

http://kipublication...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)